Developed-Markets Stocks Looking Cheaper
A macro view shows compelling valuations for some international stocks.
A macro view shows compelling valuations for some international stocks.
I write an article in the monthly Morningstar InternationalInvestor newsletter that looks at Morningstar's international coverage from a macroeconomic perspective. This macro view provides insight into how oversold the market currently is. In order to provide a margin of safety, we want to buy stocks at a significant discount to fair value. In this article, I've updated two charts that provide useful information in identifying how big the margin of safety is for the market.
One table shows the median price/fair value ratio of Morningstar's coverage of U.S. stocks, international stocks, and then international stocks broken down into developed markets and emerging markets. This ratio computes the current stock price divided by Morningstar's fair value estimate. A ratio of 1 says the stock is trading exactly at our fair value, anything below 1 shows the stock at a discount and anything above 1, at a premium. The median is the point where half the stocks have a higher ratio and half have a lower ratio. I use the median instead of the mean (or average), because some very expensive stocks can skew the mean higher and make stocks in general look more overvalued than they really are.
The other chart graphically shows Morningstar's star ratings by uncertainty rating, broken out by developed markets and emerging markets. These graphs allow the reader to quickly see the distribution of rankings of Morningstar's international coverage. The star rating is dependent on the discount or premium of the stock to our fair value estimate as well as the uncertainty rating of the stock. The higher the uncertainty rating, the greater the discount needed to increase the star rating. I developed these graphs because I wanted to take the median price/fair value ratio a step further and look at the percentage of stocks per star rating.
Following both charts over time provides information about how over- or undervalued international markets are. Currently (calculations as of Sept. 15) the median price/fair value ratios are the lowest in the two and a half years we've tracked them, with the median international stock at 0.75. This means the median stock is trading at a 25% discount to our fair value estimate. The graphs also show a tie with the previous month for the most 5-star rated international stocks we've had.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.